Amlodipine/Atorvastatin (Caduet®) Drug Use Investigation (Regulatory Post Marketing Commitment Plan)

Clinical trial NCT01107743 · COMPLETED

Trial details

NCT number: NCT01107743
Sponsor: Pfizer's Upjohn has merged with Mylan to form Viatris Inc.
Status: COMPLETED
Study type: OBSERVATIONAL

Hypertension Angina Pectoris Hypercholesterolemia Familial Hypercholesterolemia

Start date: 2010-06-01
Primary completion: 2012-04-01
Enrollment: 1291

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.